Download:
pdf |
pdfOMB Control Number 0920-1282
Performance Measures Project
Request for GenIC Approval (for data collection in 2023, 2024, 2025)
Date: November 22, 2024
CIO: NCHHSTP/DSTDP/PDEB
PROJECT TITLE: Revised- Enhancing STI and Sexual Health Clinic Infrastructure (ESSHCI)
PURPOSE AND USE OF COLLECTION: Performance measurement- The revised Enhancing STI
and Sexual Health Clinical Infrastructure (ESSHCI) Cooperative Agreement (CoAg) aims to
strengthen clinic infrastructure and expand access to comprehensive sexual health services in highburden and underserved areas. ESSHCI supports clinic strategies for:
A. Fostering community engagement and strategic partnerships to support the expansion of sexual
health services.
B. Strengthening clinic infrastructure and provision of sexual health services.
C. Conducting short-term activities to expand access to STI prevention and other sexual health
services supporting a syndemic approach.
Due to a 60% reduction in funding, of $5.2 million annually, for years 2 to 5, the program
requirements have been scaled back to de-emphasize requirements and support these strategies as
allowable activities to be implemented in years 2 – 5. The performance measures are revised to
align to the reduction in program capacity and focus. The annualized burden hours for reporting
have been reduced from 2,392 to 572 annualized burden hours. Reporting will be reduced from biannual to annual reporting. Performance measures for Strategies A and C will no longer be collected
under this revision.
Project outcomes include increased community involvement in clinic-level planning, increased
engagement with public health partners, increased access to & capacity to provide comprehensive
sexual health services, improved patient clinic experience, increased identification of new STIs, and
increased linkage to prevention and care services for co-occurring conditions.
The CDC will use performance measures for PS23-0011 to monitor the progress and achievement
of outcomes of this project. The performance measures associated with this CoAg are intended to
be used by CDC and recipients to track the implementation of the program, assess progress toward
achieving intended outcomes, and ensure accountability to interested parties (e.g., funders, public)
by demonstrating how funds are being utilized. Additionally, they will provide insights to identify
areas for improvement and technical assistance needs, with the ultimate goal of strengthening clinic
infrastrcutre and expanding access to comprehensive sexual health services. .
NUMBER AND TITLE OF NOFO: CDC-RFA-PS-23-0011 Enhancing STI and Sexual Health Clinic
Infrastructure (ESSHCI)
NUMBER OF PARTICIPATING RECIPIENTS: 26 recipients representing state health departments,
academic institutions, and non-governmental organizations.
DESCRIPTION OF NOFO (check all that apply):
__
Funds all 50 states
__
Has budget higher than $10 million per year
_X_
Has significant stakeholder interest (e.g. partners, Congress)
Please elaborate:
Through RFA PS-23-0011, CDC initially awarded $50,000,000 for a 5-year period to 26 recipients
(Att 1- List of funded ESSHCI recipients) to implement strategies to strengthen clinic infrastructure
and expand access to comprehensive sexual health services. This cooperative agreement included
the implementation of two required strategies, A & B, and an optional strategy, C. Strategy A
(required strategy for year 1) will foster community engagement and strategic partnerships to
support the expansion of sexual health services. The associated activities under this strategy include
engaging priority populations disproportionately impacted by STIs, mobilizing public health partners,
and developing a plan to increase access to quality comprehensive sexual health services. Strategy
B (strategy for years 2 – 5) will strengthen clinic infrastructure and provision of comprehensive
sexual health services. Associated activities include conducting clinic infrastructure assessment,
implementing a plan to increase access to sexual health services, enhancing clinic sexual health
services, and assessing and improving the patient clinic experience. Strategy C (optional strategy for
years 1 – 5) will fund a subset of proposed short-term activities each budget period to expand
access to STI prevention and other sexual health services supporting a syndemic approach.
The ESSCHI NOFO outcomes include increased community involvement in clinic-level planning,
increased engagement with public health partners, increased access to & capacity to provide
comprehensive sexual health services, improved patient clinic experience, increased identification of
new STIs, and increased linkage to prevention and care services for co-occurring conditions. To
address inequities and gaps in sexual health services, this cooperative agreement will prioritize
communities with high STI burdens and unmet needs for STI clinical services.
As this cooperative agreement represents new funding to strengthen sexual health clinic
infrastructure, many stakeholders within the recipients’ respective communities, CDC, and HHS are
invested and interested in the program and its outcomes to enhance STI and sexual health clinic
infrastructure.
PERFORMANCE METRICS USED & JUSTIFICATIONS:
The revised performance measures for the ESSCHI NOFO are designed to demonstrate the
program outcomes, strengthen the evidence base for specific program strategies, and clarify their
effectiveness across different populations, settings, and contexts. These measures are essential for
driving continuous program improvement. Due to reduced funding, the performance measures have
been streamlined to reduce reporting burden while maintaining their alignment with key program
strategies and outcomes and ensuring efficient use of resources and adherence to program
requirements. (Att 2- Technical Specifications-PS23-0011_Revised for Y2-5v3)
The performance measures have been revised to focus on Strategy B: Strengthen clinic
infrastructure and provision of comprehensive sexual health services. Data collection has been
streamlined to six key performance measures (reduced from 13) involving both qualitative and
1
quantitative variables. These measures are required to be reported by all recipients to assess clinics’
capacity to provide quality comprehensive sexual health services (Outcome 1) and the identification
of new STIs by clinic (Outcome 3); (Att3a-ESSHCI Performance Measures Report-Revised for
Y2-5.V4).
The six measures include a summary of the standardized Quality STD Clinical Services (QCS)
assessment (Att3b- ESSHCI_STD QCS Assessment_10.01.24V), which recipients must complete
and report as part of their implementation activities to assess clinic capacity for providing
comprehensive sexual health services (Outcome 1). For performance measures related to
Outcomes 3, aggregated data will be stratified by age, gender, race and ethnicity, sexual orientation,
and insurance status where applicable (Att3a-ESSHCI Performance Measures Report-Revised
for Y2-5.V4). Race and ethnicity will be collected at the local level according to OMB standards,
noting that Hispanic or Latino persons can be of any race.
Performance measures for Strategies A and C will no longer be collected under this revision.
All performance measures will be reported in aggregate by recipients to the CDC. Recipients will
submit the reports annually, instead of biannually, using the reporting templates provided by the
CDC (Att3a-ESSHCI Performance Measures Report-Revised for Y2-5.V4, Att3b-ESSHCI_STD
QCS Assessment_10.01.24V). Annual reporting is essential for for the CDC to monitor program
performance, quickly identify potential inefficiencies, and provide timely assistance to recipients.
This Generic IC request aligns with the purpose of this ICR, ensuring performance measurement for
for CDC cooperative agreements by requiring recipients to submit select, aggregate data points
once a year (Att 4- Recipient email-PS23-0011_Y2-5 Revised). The data collection templates are
fully consistent with the intent, format, type, and level of data outlines in this Generic IC, ensuring
accurate and streamlined performance measurement reporting.
CERTIFICATION:
I certify the following to be true:
1. The collection is non-controversial and does not raise issues of concern to other federal
agencies.
2. Information gathered is meant primarily for program improvement and accountability; it is not
intended to be used as the principal basis for policy decisions.
Name: __ Tosin Ariyo | Oluwatosin Ariyo________________________________
To assist review, please answer the following questions:
ANNUALIZED BURDEN HOURS:
This table calculates the total estimated burden per year for all recipients.
Type of
Respondent
Form Name
No. of
Respondents
2
No. of
Responses
Avg.
Burden Per
Response
Total
Annualized
per
Respondent
Burden
Hours
State/Local
Government
STD QCS
Assessment tool
6
1
6
36
State/Local
Government
ESSHCI PMP
Reporting template
6
1
16
96
Private Institutions
STD QCS
Assessment tool
2
1
6
12
Private Institutions
ESSHCI PMP
Reporting template
2
1
16
32
Non-governmental
Organizations
STD QCS
Assessment tool
18
1
6
108
Non-governmental
Organizations
ESSHCI PMP
Reporting template
18
1
16
288
66
572
Totals
26
TOTAL BURDEN HOURS FOR THIS GENIC:
This table specifies the calendar years in which information will be collected and calculates the total
burden hours requested over the approved timeframe of the generic.
Data Collection Timeframe (List up to 3
Years)
No. Years
Requested
2025, 2026, 2027
3
Annualized
Burden Hours
572
Total Burden Hours
for this GENIC
1,716
See examples provided with this template.
FEDERAL COST: The estimated annual cost to the Federal government is ___$87,003.83___
The cost is based on providing technical assistance to jurisdictions on the Data Collection Tools and
review, analysis, and reporting of the submitted data by three personnel: one GS-12, Step 1 staff at
37.5% time effort (annual salary: $91,897); one GS-12, Step 4 staff at 37.5% time effort staff (annual
salary: $101,086); and one GS-14, Step 5 staff at 10% (annual salary: $146,352) SALARY TABLE
2024-ATL (opm.gov). Total: $34,461.38 + $37,907.25 + $14,635.20 = $87,003.83
ADMINISTRATION OF THE INSTRUMENT:
1. How will you collect the information? (Check all that apply)
[ ] Web-based
3
[ ] Email
[ ] Postal Mail
[ X ] Other, Explain: Other, CDC’s Secure Access Management System is used for the
submission of data.
4
File Type | application/pdf |
File Title | DOCUMENTATION FOR THE GENERIC CLEARANCE |
Author | 558022 |
File Modified | 2024-11-22 |
File Created | 2024-11-22 |